On Wednesday, Shares of The Coca-Cola Co (NYSE:KO), gained 1.34% to $41.51. The stock attained the volume of 14.40 million shares.
The year-to-date (YTD) performance reflected a 0.84% above last year. During the past month the stock gains 7.66%, bringing three-month performance to 4.91% and six-month performance to 2.86%. The stock holds the market capitalization of $180.61B.
Colombia fined sugar producers a total of $112 million for anti-competitive practices following a complaint lodged in 2010 by Coca-Cola Femsa SAB, Nestle de Colombia SA and other buyers, according to Bloomberg.
The nation’s antitrust regulator fined 14 companies for conspiring to block sugar imports from Bolivia, Guatemala, El Salvador and Costa Rica. Fourteen company executives were also fined, the regulator said in an e-mailed statement Wednesday.
The sugar companies “deliberately conceived and executed a strategy that was anti-competitive, illegal, coordinated and prolonged, aimed at blocking sugar imports to Colombia, to avoid an improvement in supply and reduced internal prices paid by consumers and the industry,” the regulator found. Bloomberg Reports
The Coca-Cola Company, a beverage company, manufactures and distributes various nonalcoholic beverages worldwide. The company primarily offers sparkling beverages and still beverages.
Shares of Johnson & Johnson (NYSE:JNJ), inclined 1.69% to $95.00, during its last trading session. The share price of this stock traded recently in a range of $93.44 to $95.42. The company now has a market value of $258.74 billion.
For this company, beta value at 0.61 represents it is more volatile to the shift in the market. If we take a look on its volatility, 1.95% was seen in a week and for the month it was 1.91%.
Johnson & Johnson, declared the completion of the divestiture of its Cordis business to Cardinal Health for an approximate value of $2 billion, subject to customary adjustments.
The Cordis business is a global leader in the development and manufacture of interventional vascular technology and generated net revenues of about $780 million in 2014.
Johnson & Johnson remains dedicated to combating cardiovascular disease through its electrophysiology business, Biosense Webster, in the Medical Devices segment, and its leading cardiovascular medicine, XARELTO®, in the Pharmaceutical segment.
Johnson & Johnson, together with its auxiliaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices.
Shares of United Continental Holdings Inc (NYSE:UAL), inclined 1.54% to $51.56, during its last trading session. In the last trading session, the stock moved on low volume, trading at a volume of 7.08 M as compared to its average daily volume of 9.32 million shares.
The stock, as of recent close, has shown weekly downbeat performance of -2.77% which was maintained at -10.31% in 1-month period.
A United Airlines flight from Houston to San Francisco was rerouted to Albuquerque, New Mexico, on Tuesday when a crew member became ill, the airline said.
United said in a statement that the crew member was unable to continue on the flight and received assistance. CNN stated that the crew member was the co-pilot, who was able to walk off the plane, according to Reuters.
After stopping in Albuquerque, the plane continued on to San Francisco, United said. The incident came one day after an American Airlines pilot died in the cockpit during a flight.
United Continental Holdings, Inc., together with its auxiliaries, provides air transportation services in North America, the Asia-Pacific, Europe, the Middle East, Africa, and Latin America.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
